{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:57:41Z","timestamp":1790776661040,"version":"4.1.0"},"reference-count":29,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Primary Health Care"],"published-print":{"date-parts":[[2015,5]]},"abstract":"\n Aim<\/jats:title>\n To examine beliefs about irritable bowel syndrome (IBS) management among\n primary care physicians.<\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n There have been considerable advances in evidence synthesis concerning\n management of IBS in the last five years, with guidelines for its management in\n primary care published by the National Institute for Health and Care Excellence\n (NICE).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This was a cross-sectional web-based questionnaire survey of 275 primary\n care physicians. We emailed a link to a SurveyMonkey questionnaire, containing\n 18 items, to all eligible primary care physicians registered with three\n clinical commissioning groups in Leeds, UK. Participants were given one month\n to respond, with a reminder sent out after two weeks.<\/jats:p>\n <\/jats:sec>\n \n Findings<\/jats:title>\n One-hundred and two (37.1%) primary care physicians responded. Among\n responders, 70% believed IBS was a diagnosis of exclusion, and >80% checked\n coeliac serology often or always in suspected IBS. Between >50% and >70%\n believed soluble fibre, antispasmodics, peppermint oil, and psychological\n therapies were potentially efficacious therapies. The respondents were less\n convinced that antidepressants or probiotics were effective. Despite perceived\n efficacy of psychological therapies, 80% stated these were not easily\n available. Levels of use of soluble fibre, antispasmodics, and peppermint oil\n were in the range of 40% to >50%. Most primary care physicians obtained\n up-to-date evidence about IBS management from NICE guidelines. Most primary\n care physicians still believe IBS is a diagnosis of exclusion, and many are\n reluctant to use antidepressants or probiotics to treat IBS. More research\n studies addressing diagnosis and treatment of IBS based in primary are\n required.<\/jats:p>\n <\/jats:sec>","DOI":"10.1017\/s1463423614000383","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T06:10:59Z","timestamp":1412662259000},"page":"263-269","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":37,"title":["Beliefs about management of irritable bowel syndrome in primary care:\n cross-sectional survey in one locality"],"prefix":"10.1017","volume":"16","author":[{"given":"Uday N.","family":"Shivaji","sequence":"first","affiliation":[{"name":"St. James\u2019s University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[{"name":"St. James\u2019s University Hospital"},{"name":"Leeds University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"key":"S1463423614000383_manual_ref-5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2008.12.015","article-title":"Burden of digestive diseases in the United States part I: Overall and upper gastrointestinal diseases","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"S1463423614000383_manual_ref-29","first-page":"176","article-title":"Evaluation of patients who meet clinical criteria for irritable bowel syndrome","volume":"89","author":"Tolliver","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"S1463423614000383_manual_ref-14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.159723"},{"key":"S1463423614000383_manual_ref-4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3154"},{"key":"S1463423614000383_manual_ref-31","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"van Rheenen","year":"2010","journal-title":"British Medical Journal"},{"key":"S1463423614000383_manual_ref-12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in irritable bowel syndrome: systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008b","journal-title":"British Medical Journal"},{"key":"S1463423614000383_manual_ref-26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00042737-199707000-00008","article-title":"Irritable bowel syndrome: the view from general practice","volume":"9","author":"Thompson","year":"1997","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"S1463423614000383_manual_ref-15","first-page":"47","article-title":"How general practitioners manage patients with irritable bowel syndrome. Data from a German urban area","volume":"47","author":"Franke","year":"2009","journal-title":"Romanian Journal of Internal Medicine \u2013 Revue roumaine de m\u00e9decine interne"},{"key":"S1463423614000383_manual_ref-3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.dld.2005.06.011","article-title":"The general practitioner's approach to irritable bowel syndrome: from intention to practice","volume":"37","author":"Bellini","year":"2005","journal-title":"Digestive and Liver Disease"},{"key":"S1463423614000383_manual_ref-9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1572-0241.2007.01740.x","article-title":"Irritable bowel syndrome: a 10-year natural history of symptoms, and factors that influence consultation behavior","volume":"103","author":"Ford","year":"2008a","journal-title":"American Journal of Gastroenterology"},{"key":"S1463423614000383_manual_ref-19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ajg.2012.131","article-title":"Effect of gender on prevalence of irritable bowel syndrome in the community: Systematic review and meta-analysis","volume":"107","author":"Lovell","year":"2012b","journal-title":"American Journal of Gastroenterology"},{"key":"S1463423614000383_manual_ref-11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","article-title":"Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"58","author":"Ford","year":"2009c","journal-title":"Gut"},{"key":"S1463423614000383_manual_ref-6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.08.048"},{"key":"S1463423614000383_manual_ref-7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/ajg.2009.223","article-title":"Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis","volume":"104","author":"Ford","year":"2009a","journal-title":"American Journal of Gastroenterology"},{"key":"S1463423614000383_manual_ref-18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of, and risk factors for, irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012a","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"S1463423614000383_manual_ref-16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.005"},{"key":"S1463423614000383_manual_ref-25","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.47"},{"key":"S1463423614000383_manual_ref-28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.gastro.2010.07.053","article-title":"Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome","volume":"140","author":"Tillisch","year":"2011","journal-title":"Gastroenterology"},{"key":"S1463423614000383_manual_ref-8","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.22"},{"key":"S1463423614000383_manual_ref-24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06581-3"},{"key":"S1463423614000383_manual_ref-13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.15.1793"},{"key":"S1463423614000383_manual_ref-22","unstructured":"National Institute for Health and Clinical Excellence.\n 2008: Irritable bowel syndrome in adults: diagnosis and management of irritable\n bowel syndrome in primary care. Retrieved 4 April 2014 from\n http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG061NICEGuideline.pdf"},{"key":"S1463423614000383_manual_ref-27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.1.78"},{"key":"S1463423614000383_manual_ref-10","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.69"},{"key":"S1463423614000383_manual_ref-17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.061"},{"key":"S1463423614000383_manual_ref-23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1053\/j.gastro.2013.04.049","article-title":"Report from the multinational irritable bowel syndrome initiative 2012","volume":"144","author":"Pimentel","year":"2013","journal-title":"Gastroenterology"},{"key":"S1463423614000383_manual_ref-21","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.167270"},{"key":"S1463423614000383_manual_ref-30","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/BF02212678","article-title":"Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity","volume":"40","author":"Trimble","year":"1995","journal-title":"Digestive Diseases and Sciences"},{"key":"S1463423614000383_manual_ref-20","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296097"}],"container-title":["Primary Health Care Research & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1463423614000383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:46:59Z","timestamp":1780652819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1463423614000383\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1463423614000383"],"URL":"https:\/\/doi.org\/10.1017\/s1463423614000383","relation":{},"ISSN":["1463-4236","1477-1128"],"issn-type":[{"value":"1463-4236","type":"print"},{"value":"1477-1128","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,7]]},"assertion":[{"value":"\u00a9 Cambridge University Press 2014\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}